Understanding dendritic cell and T‐lymphocyte traffic through the analysis of chemokine receptor expression

By F. Sallusto, A. Lanzavecchia. Immunological Reviews, 2000

598 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/57e39d3b2c0c4a00568e906fc829c8e135f68a6f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

In Oncology

Citations in the corpus

International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors (2014, unknown): “…and maturation into potent APCs imply downregulation of tissue-specific chemokine receptors such as CCR1, CCR5, and CCR6 and upregulation of CCR7, which guides DCs from sites of Ag exposure to the local lymph nodes via draining afferent lymphatic vessels (Sallusto and Lanzavecchia, 2000).”
Immune function of microglia (2001, background): “Such regulation could occur at various steps after initiation of CNS-specific immune responses: (1) during T-cell recruitment to the CNS, as Th1 and Th2 cells seem to respond to different subsets of chemokines (e.g., Th1 cells respond to MIP-1a, MIP1b, IP-10, and RANTES, whereas Th2 cells are prefer”
Chemokines and chemokine receptors in leukocyte trafficking. (2002, background): “Memory T cells are generally grouped into central memory and effector memory T cell populations (158).”
Chemokine receptors: multifaceted therapeutic targets (2002, background): “The roles of chemokines in dendritic cell biology and disease should not be neglecte”
Mediators of Chronic Obstructive Pulmonary Disease (2004, background): “CCR7 plays a role in the migration of dendritic cells to regional lymph nodes, and therefore blocking this receptor might suppress antigen presentation (Sallusto and Lanzavecchia, 2000).”
The Chemokine Superfamily Revisited (2012, unknown): “Thus, CCR4-expressing T cells are first exposed to CCL17 on skin endothelial cells and then guided into skin tissues by CCL22 (Mariani et al., 2004).”